Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects

Plasma apolipoprotein A-IV (apoA-IV) levels are found elevated in hypertriglyceridemic patients. However, the relationship between plasma apoA-IV level and postprandial lipemia is not well known and remains to be elucidated. Thus, our objective was to study the relationship between plasma apoA-IV an...

Full description

Bibliographic Details
Main Authors: Bruno Vergès, Bruno Guerci, Vincent Durlach, Catherine Galland-Jos, Jean Louis Paul, Laurent Lagrost, Philippe Gambert
Format: Article
Language:English
Published: Elsevier 2001-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520315315
id doaj-cd05732b9b1642a18a11e85229c75ad0
record_format Article
spelling doaj-cd05732b9b1642a18a11e85229c75ad02021-04-27T04:40:01ZengElsevierJournal of Lipid Research0022-22752001-12-01421220212029Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjectsBruno Vergès0Bruno Guerci1Vincent Durlach2Catherine Galland-Jos3Jean Louis Paul4Laurent Lagrost5Philippe Gambert6To whom correspondence should be addressed at Service Endocrinologie, Diabétologie et Maladies Métaboliques, Hôpital du Bocage, CHU, F-21000 Dijon, France.; Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, CHU de Dijon, 21000 Dijon, France; INSERM U498, CHU Dijon, FranceCentre d'Investigation Clinique (CIC-Inserm/CHU de Nancy), Service de Diabétologie, Maladies Métaboliques et Maladies de la Nutrition, Hôpital Jeanne d'Arc, 54201 Toul, FranceService d'Endocrinologie, Maladies Métaboliques et Médecine Interne, CHU de Reims, 51092 Reims, FranceService d'Endocrinologie, Diabétologie et Maladies Métaboliques, CHU de Dijon, 21000 Dijon, FranceLaboratoire de Biochimie, Hôpital Européen Georges Pompidou, 75015 Paris, FranceINSERM U498, CHU Dijon, FranceINSERM U498, CHU Dijon, FrancePlasma apolipoprotein A-IV (apoA-IV) levels are found elevated in hypertriglyceridemic patients. However, the relationship between plasma apoA-IV level and postprandial lipemia is not well known and remains to be elucidated. Thus, our objective was to study the relationship between plasma apoA-IV and postprandial TG after an oral fat load test (OFLT). Plasma apoA-IV was measured at fast and during an OFLT in 16 normotriglyceridemic, normoglucose-tolerant android obese subjects (BMI = 34.6 ± 2.9 kg/m2) and 30 normal weight controls (BMI = 22.2 ± 2.3 kg/m2). In spite of not statistically different fasting plasma TG levels in controls and obese patients, the former group showed an altered TG response after OFLT, featuring increased nonchylomicron TG area under the curve (AUC) compared with controls (516 ± 138 vs. 426 ± 119 mmol/l·min, P < 0.05). As compared to controls, obese patients showed increased apoA-IV levels both at fast (138.5 ± 22.4 vs. 124.0 ± 22.8 mg/l, P < 0.05) and during the OFLT (apoA-IV AUC: 79,833 ± 14,281 vs. 68,176 ± 17,463 mg/l·min, P < 0.05). Among the whole population studied, as among the control and obese subgroups, fasting plasma apoA-IV correlated significantly with AUC of plasma TG (r = 0.60, P = 0.001), AUC of chymomicron TG (r = 0.45, P < 0.01), and AUC of nonchylomicron TG (r = 0.62, P < 0.001). In the multivariate analysis, fasting apoA-IV level constituted an independent and highly significant determinant of AUC of plasma TG, AUC of chymomicron TG, AUC of nonchylomicron TG, and incremental AUC of plasma TG. In conclusion, we show a strong link between fasting apoA-IV and postprandial TG metabolism. Plasma fasting apoA-IV is shown to be a good marker of TG response after an OFLT, providing additional information on post-load TG response in conjunction with other known factors such as fasting TGs.—Vergès, B., B. Guerci, V. Durlach, C. Galland-Jos, J. L. Paul, L. Lagrost, and P. Gambert. Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J. Lipid Res. 2001. 42: 2021–2029.http://www.sciencedirect.com/science/article/pii/S0022227520315315triglyceridesoral fat loadsyndrome Xkinetics
collection DOAJ
language English
format Article
sources DOAJ
author Bruno Vergès
Bruno Guerci
Vincent Durlach
Catherine Galland-Jos
Jean Louis Paul
Laurent Lagrost
Philippe Gambert
spellingShingle Bruno Vergès
Bruno Guerci
Vincent Durlach
Catherine Galland-Jos
Jean Louis Paul
Laurent Lagrost
Philippe Gambert
Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
Journal of Lipid Research
triglycerides
oral fat load
syndrome X
kinetics
author_facet Bruno Vergès
Bruno Guerci
Vincent Durlach
Catherine Galland-Jos
Jean Louis Paul
Laurent Lagrost
Philippe Gambert
author_sort Bruno Vergès
title Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
title_short Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
title_full Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
title_fullStr Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
title_full_unstemmed Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
title_sort increased plasma apoa-iv level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2001-12-01
description Plasma apolipoprotein A-IV (apoA-IV) levels are found elevated in hypertriglyceridemic patients. However, the relationship between plasma apoA-IV level and postprandial lipemia is not well known and remains to be elucidated. Thus, our objective was to study the relationship between plasma apoA-IV and postprandial TG after an oral fat load test (OFLT). Plasma apoA-IV was measured at fast and during an OFLT in 16 normotriglyceridemic, normoglucose-tolerant android obese subjects (BMI = 34.6 ± 2.9 kg/m2) and 30 normal weight controls (BMI = 22.2 ± 2.3 kg/m2). In spite of not statistically different fasting plasma TG levels in controls and obese patients, the former group showed an altered TG response after OFLT, featuring increased nonchylomicron TG area under the curve (AUC) compared with controls (516 ± 138 vs. 426 ± 119 mmol/l·min, P < 0.05). As compared to controls, obese patients showed increased apoA-IV levels both at fast (138.5 ± 22.4 vs. 124.0 ± 22.8 mg/l, P < 0.05) and during the OFLT (apoA-IV AUC: 79,833 ± 14,281 vs. 68,176 ± 17,463 mg/l·min, P < 0.05). Among the whole population studied, as among the control and obese subgroups, fasting plasma apoA-IV correlated significantly with AUC of plasma TG (r = 0.60, P = 0.001), AUC of chymomicron TG (r = 0.45, P < 0.01), and AUC of nonchylomicron TG (r = 0.62, P < 0.001). In the multivariate analysis, fasting apoA-IV level constituted an independent and highly significant determinant of AUC of plasma TG, AUC of chymomicron TG, AUC of nonchylomicron TG, and incremental AUC of plasma TG. In conclusion, we show a strong link between fasting apoA-IV and postprandial TG metabolism. Plasma fasting apoA-IV is shown to be a good marker of TG response after an OFLT, providing additional information on post-load TG response in conjunction with other known factors such as fasting TGs.—Vergès, B., B. Guerci, V. Durlach, C. Galland-Jos, J. L. Paul, L. Lagrost, and P. Gambert. Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J. Lipid Res. 2001. 42: 2021–2029.
topic triglycerides
oral fat load
syndrome X
kinetics
url http://www.sciencedirect.com/science/article/pii/S0022227520315315
work_keys_str_mv AT brunoverges increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT brunoguerci increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT vincentdurlach increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT catherinegallandjos increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT jeanlouispaul increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT laurentlagrost increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
AT philippegambert increasedplasmaapoaivlevelisamarkerofabnormalpostprandiallipemiaastudyinnormoponderalandobesesubjects
_version_ 1721506955323768832